Clinical Trial Efficiency: Top Risk Indicators And Solutions For Site Performance

By Anna Hrovat-Staedter, Senior Product Marketing Manager

Clinical trials are a critical part of the medical research process, but they often encounter significant hurdles such as unmet recruitment targets and loss of patient data due to non-adherence to protocols. These issues can lead to expensive contingencies, slowing down the progress of essential research. To mitigate these challenges, study teams are advised to enhance their oversight and concentrate on vital risk indicators.

These indicators include monitoring if site staff has accessed and completed the necessary training, passed evaluations, acknowledged crucial study documents and alerts, and pre-screened an adequate number of patients to meet recruitment objectives. The application of technology and proactive oversight can significantly contribute to the successful implementation of a trial and decrease administrative burdens for site teams.

By taking these steps, learn how research teams can ensure the smooth running of clinical trials and pave the way for medical advancements.